A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma

Cancer

Volumn 86, Issue 2, 1999, Pages 265-273

  Dautzenberg, Bertrand ^a   Arriagada, Rodrigo ^b   Chammard, Agnès Boyer ^b   Jarema, Alina ^b   Mezzetti, Maurizio ^b   Mattson, Karin ^b   Lagrange, Jean L ^b   Le Pechoux, Cécile ^b   Lebeau, Bernard ^b   Chastang, Claude ^b   Marzecki, Zbigniew ^b   Santos Miranda, Juan A ^b   Le Chevalier, Thierry ^b   Stankiewicz, Danuta ^b   Volterrani, Fabio ^b   Leclerc, Pascal ^b   Maasilta, Paula ^b   Guérin, Robert A ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b NONE

Author keywords

Adjuvant treatment; Adverse reactions; Nonsmall cell lung carcinoma; Overall survival; R radiotherapy; Randomized trial

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTICENTER STUDY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY;

EID: 0033566002     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990715)86:2<265::AID-CNCR10>3.0.CO;2-B     Document Type: Article

References (36)

1. Schield JW. Surgical therapy for carcinoma of the lung. Clin Chest Med 1993;14:121-47.
2. Choi NC. Controversies in the role of postoperative radiotherapy in stage II and IIIA resected non small cell carcinoma. Int Radiat Oncol Biol Phys 1991;20:1137-41.
3. Lad T, Rubinstein L, Sadeghi A, and the LCSG. The benefit of adjuvant treatment for resected locally advanced non small cell lung cancer. J Clin Oncol 1988;6:9-17.
4. Emami B, Perez CA. Lung: In: Perez CA, Brady LW.Principle and practice of radiation oncology. 2nd edition. Philadelphia: J. B. Lippincott, 1992:806-36.
5. Paterson R, Russel MH. Clinical trials in malignant disease. IV. Lung cancer: value of postoperative radiotherapy. Clin Radiol 1962;36:914-25.
6. Bangma PJ. Postoperative radiotherapy. In: Deley TH. Carcinoma of the bronchus. Modern radiotherapy. New York: Appleton-Century-Crofts, 1972:163-70.
7. Israel L, Bonadonna G, Sylvester R, and Members of the EORTC Lung Cancer Group. Controlled study with adjuvant radiotherapy, chemotherapy, immunotherapy, and chemoimmunotherapy in operable squamous carcinoma of the lung. In: Muggia F. Rozencweig M, editors. Lung cancer: progress in therapeutic research. New York: Raven Press, 1979:443-52.
8. Israel L, Depierre A, Sylvester R. Influence of postoperative radiotherapy on epidermoid carcinoma with regard to nodal status: preliminary results of the EORTC protocol 08741. Recent Results Cancer Res 1979;68:242-3.
9. Van Houtte P, Rocmans P, Smets P, Goffin JC, Lustman-Maréchal J, Vanderhoeft P, et al. Postoperative radiation therapy in lung cancer: a controlled trial after resection of curative design. Int J Radiat Oncol Biol Phys 1980;6:983-6.
10. Lung Cancer Study Group. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. N Engl J Med 1986;315:1377-81.
11. British Medical Research Council/Lung Cancer Working Party. Randomised trial of surgical resection with or without postoperative radiotherapy (RT) in non small cell lung cancer (NSCLC) [abstract]. Lung Cancer 1994;11 (Suppl 1):A571.
12. Debevec M, Bitenc M, Vidmar S, Rott T, Orel J, Strojan P, et al. Postoperative radiotherapy for radically resected N2 non small cell lung cancer (NSCLC): randomised clinical study 1988-1992. Lung Cancer 1996;14:99-107.
13. Mei W, Xianzhi G, Weibo Y, Zongyi Y, Zhixian Z, Yanjun M, et al. Randomized clinical trial of post-operative irradiation after surgery for nonsmall cell lung carcinoma (NSCLC). Lung Cancer 1994,10:386-94.
14. Ricci SB, Milani F, Gramaglia A, Villa S. Surgery (S) vs. surgery + radiotherapy (S/RT) in T2-N1-2 non small cell lung carcinoma (NSCLC): an analysis of man term data [abstract]. Lung Cancer 1991;7:99.
15. Lafitte JL, Ribet ME, Prévost BM, Gosselin BH, Copin MC, Brichet AH. Postresection irradiation for T2N0MO non-small cell carcinoma: a prospective, randomized study. Ann Thorac Surg 1996;62:830-4.
16. Mountain CF. A new international staging system for lung cancer. Chest 1986;89:22S-33S.
17. ICRU (International Commission of Radiation Units and Measurements). Dose signification for reporting external beam therapy with photons and electrons. Report ICRU 1978; no. 29.
18. Chavaudra J, Arriagada R. Radiotherapy planning in lung cancer.The Gustave-Roussy Institute approach. Cancer Treat Symptoms 1985;2:87-91.
19. World Health Organization. Handbook for reporting results of cancer treatment. Geneva: WHO, 1979:48.
20. George SL, Desu MM. Planning the size and duration of a clinical trial studying the time to some critical event. J Chron Dis 1974;27:15-24.
21. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
22. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-49.
23. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187-220.
24. Gail M, Simon R. Testing for qualitative interactions between treatment effects and patients subsets. Biometrics 1985;41:361-73.
25. Martini N, Ginsberg RJ. Surgical approach to non small cell lung cancer. Hematol Oncol Clin North Am 1990;4:1121-31.
26. Lad T. Postoperative adjuvant therapy in stage 1, 2 and 3A non small cell lung cancer. Hematol Oncol Clin North Am 1990;4:1111-9.
27. Green MR. New adjuvant strategies for the management of resectable non small cell lung carcinoma. Chest 1993;103: 352-5.
28. Choi NCH, Grillo HE, Gardiello M, Scannell JG, Wilkins EW. Basis for new strategies in postoperative radiotherapy of bronchogenic carcinoma, Int J Radiat Oncol Biol Phys 1980; 6:31-5.
29. Pearson FG, Delarue NC, Ilves R, Todd TRJ, Cooper JD. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J Thorac Cardiovasc Surg 1982;83:1-11.
30. Martini N, Flehinger BJ, Zaman MB, Beattie EJ Jr. Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases. Ann Surg 1983;198:386-97.
31. Kirsh MM, Sloan H. Mediastinal metastases in bronchogenic carcinoma: influence of postoperative irradiation, cell type and location. Ann Thorac Surg 1982;33:459-63.
32. Doucette JA. Improved survival of patients with unresectable non small cell bronchogenic carcinoma by an innovative high-dose en-bloc radiotherapeutic approach. Cancer 1981;48:101-9.
33. Choi NC, Kanarek DJ, Grillo HC. Effects of postoperative radiotherapy on changes in pulmonary function in patients with stage II and IIIA lung carcinoma. lnt J Radiat Oncol Biol Phys 1990;18:95-9.
34. Stewart JR, Fajardo LF, Gilette SM, Constine LS. Radiation injury to the heart. lnt J Radiat Oncol Biol Phys 1995;31: 1205-11.
35. Sawyer TE, Bonner JA, Gould PM, Foote RL, Deschamps C, Trastek VF et al. The Impact of surgical adjuvant thoracic radiation therapy for patients with non small cell lung carcinoma with ispsilateral medistinal lymph node involvement. Cancer 1997;80:1399-408.
36. Sawyer TE, Bonner JA, Gould PM, Foote RL, Deschamps C, Trastek VF et al. Effectiveness of postoperative irradiation in stage IIIA non-small cell lung cancer according to regression tree analysis of recurrence risks. Ann Thorac Surg 1997;64: 1402-8.